Damora Therapeutics Cash Flow Statement (2019-2026) | DMRA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.27M	-12.94M	-13.47M	-16.94M	-17.12M	-13.62M	-13.53M	-13.49M	-10.74M	-8.14M	-6.47M	-5.48M	-5.34M	-3.88M	4.60M	-2.53M	-3.44M	-3.13M	-196.88M	-27.78M
Depreciation and Depletion (Quarter)	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.02M	0.02M	0.21M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.99M	1.22M	1.24M	1.40M	1.42M	1.40M	1.35M	1.43M	1.44M	1.46M	1.09M	1.36M	0.89M	0.68M	0.31M	0.18M	0.17M	0.16M	0.48M	8.12M
Gains from Sales and Divestitures (Quarter)													0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Gains from Investment Securities (Quarter)	0.41M	0.41M	0.66M	1.65M	1.77M	0.45M	-0.94M	7.55M	7.67M	0.40M	-0.08M		1.44M	0.18M	-1.94M		0.24M		-0.67M	4.05M
Non-cash Items (Quarter)	0.96M	2.06M	1.36M	0.34M		0.00M		1.43M	3.26M										8.48M	11.42M
Cash from Operations (Quarter)	-11.17M	-9.16M	-17.83M	-6.80M	-14.84M	-9.85M	-11.45M	-9.10M	-7.88M	-8.45M	-11.46M	-5.90M	-4.10M	-3.69M	-4.91M	-2.40M	-2.30M	-2.60M	0.57M	-20.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.33M	-0.50M	1.15M	0.11M	-0.55M	0.74M	-0.87M	0.12M	0.08M	0.21M	0.03M	0.01M	0.15M	-0.23M		0.00M	0.00M	0.01M	0.00M	0.06M
Depreciation & Amortization (CF) (Quarter)	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.02M	0.02M	0.21M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Account Payables (Quarter)	-0.20M	0.40M	-0.45M	1.68M	-0.40M	-0.91M	1.44M	0.20M	2.01M	-1.08M	-2.77M	-0.04M	-0.94M	-0.22M	-0.13M	-0.02M	0.40M	-0.24M	-0.09M	0.38M
Change in Accured Expenses (Quarter)	-0.63M	0.62M	-0.72M	1.06M	0.73M	2.13M	0.75M	2.78M	-1.14M	-1.19M	-3.78M	-1.45M	0.41M	-1.00M	-1.10M	0.38M	0.67M	0.23M	-0.18M	3.60M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	0.30M	-0.17M	4.19M	-0.11M	-6.63M	-1.06M	7.28M	-0.15M	-0.08M	-0.15M	-0.22M	-0.09M	-0.08M	-1.95M	1.17M	-0.00M	0.01M	0.00M	-0.03M	-0.05M
Investing Activities
Capital Expenditures (Quarter)	0.12M	0.05M	-0.00M	0.04M	-0.03M	0.14M	0.04M
Change in Acquisitions & Divestments (Quarter)		10.25M	14.41M	16.22M	14.19M	8.45M	18.58M	14.12M	12.33M	12.23M	9.50M	5.65M	6.00M
Cash from Investing Activities (Quarter)	5.12M	7.05M	14.41M	-10.21M	-0.05M	8.31M	14.33M	1.37M	3.09M	8.29M	9.58M	5.65M	6.00M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)						0.42M	0.07M	0.02M	2.68M	0.17M										295.92M
Additional items
Exchange Rate Effect (Quarter)	0.23M	-0.37M	-0.18M	-0.17M	-0.72M	-0.35M	1.50M	0.02M	-0.04M	0.12M	0.28M	-0.09M	-0.13M	0.47M	-0.57M	0.20M	0.51M	0.01M	-0.02M	-0.05M
Change in Cash (Quarter)	-6.04M	-2.11M	-3.42M	-17.00M	-14.87M	-1.11M	2.95M	-7.74M	-2.08M	0.00M	-1.89M	-0.29M	1.90M	-3.65M	-4.94M	-2.44M	-2.24M	-2.62M	250.04M	275.32M
Free Cash Flow (Quarter)	-11.28M	-9.21M	-17.82M	-6.84M	-14.81M	-9.98M	-11.49M	-9.10M	-7.88M	-8.45M	-11.46M	-5.90M	-4.10M	-3.69M	-4.91M	-2.40M	-2.30M	-2.60M	0.57M	-20.60M
Net Cash Flow (Quarter)	-6.04M	-2.11M	-3.42M	-17.00M	-14.89M	-1.11M	2.95M	-7.70M	-2.11M	0.00M	-1.88M	-0.25M	1.90M	-3.69M	-4.91M	-2.40M	-2.30M	-2.60M	0.57M	275.32M

Research Tools

Developers

Damora Therapeutics Cash Flow Statement (2019-2026) | DMRA

Research Tools

Developers

Damora Therapeutics Cash Flow Statement (2019-2026) | DMRA

Create an account

Sign In

Reset Password